MedTech Acquisition Corporation (MTAC) to Combine with Memic innovative Surgery

MedTech (NASDAQ:MTAC) has entered into a definitive agreement to combine with medical device-maker Memic at an enterprise value of $655 million, or 7.9x its 2024E revenue. Tel Aviv-based Memic is developing robotic surgical devices to be used in gynecological operations with a rollout initially planned for the US market this year. The combined company is
Read More